DRESS Syndrome Diagnostic Criteria
DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is diagnosed using the RegiSCAR scoring system, which classifies cases as "no," "possible," "probable," or "definite" based on clinical and laboratory findings. 1
Core Diagnostic Features
- DRESS syndrome typically presents after a latent period of 2-6 weeks following exposure to the offending drug, which distinguishes it from other drug reactions 2
- The most common clinical manifestations include:
RegiSCAR Diagnostic Criteria
The diagnosis is established through a scoring system based on the following:
Cutaneous findings:
Systemic involvement:
Hematologic abnormalities:
Organ involvement:
Other criteria:
Laboratory Evaluation
Complete blood count with differential to assess for:
Comprehensive metabolic panel to evaluate:
Additional testing:
Differential Diagnosis
DRESS syndrome must be distinguished from:
Other severe cutaneous adverse reactions:
Systemic conditions:
Prognostic Indicators
- Poor prognostic factors include:
Common Pitfalls and Caveats
- Delayed diagnosis is common due to the variable presentation and latency period of 2-6 weeks after drug initiation 2, 5
- The mortality rate is estimated at 3.8-10%, primarily due to fulminant hepatitis and liver necrosis 5, 6
- Relapse can occur in approximately 12% of cases, particularly with DRESS associated with viral reactivation 2
- Certain genetic predispositions (HLA associations) are strongly linked to specific drug reactions, such as HLA-B*58:01 with allopurinol-induced DRESS 7, 2
- DRESS syndrome must be differentiated from DRESS (Drug Reaction with Eosinophilia and Systemic) syndrome, which is mentioned as a differential diagnosis for other conditions 7